Novo Nordisk’s trial of semaglutide for obesity meets primary endpoint
Novo Nordisk has reported that its Phase IIIb STEP UP trial, aimed to assess the safety and efficacy of subcutaneous ...
clinicaltrialsarena1h
Novo Nordisk’s high-dose Wegovy increases weight loss and remains safe
Novo Nordisk has reported that its Phase IIIb STEP UP trial of subcutaneous semaglutide 7.2mg in obese adults has met its ...
The Financial Express36m
Tirzepatide for weight loss: All you need to know
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
Jim Cramer’s Comments on Novo Nordisk A/S (NVO) Surrounded Its Weight Loss Drugs Being Picked For Medicare Price Negotiations
We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...
The Financial Express3h
Blockbuster weight loss drug Tirzepatide coming to India soon: Benefits, weight loss potential, and side effects
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
The £40 weight loss jabs illegally sold on TikTok that could put you in hospital
Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...